Coronavirus: Measures for manufacturers and wholesale distributors of medicines

In the context of the restrictions caused by Covid-19, INFARMED and the DGS have published a set of guidelines for manufacturers and wholesale distributors of medicinal products for human use. The aim of these guidelines is to ensure supply to the domestic market and, at the same time, to prevent the spread of Covid-19 and protect the employees of these operators.